6 - Mano-a-Mano

Wednesday, October 11, 2023

1:30 PM – 3:15 PM US ET

Location: 210 ABC

All relevant financial disclosures have been mitigated.

Debate Style Moderator(s)

Latania Logan, MD, MSPH

Marcus Professor of Pediatric Infectious Diseases, Professor of Pediatrics
Emory University School of Medicine
Atlanta, GA, United States

Slides
Judith Guzman-Cottrill, DO (she/her/hers)

Professor, Pediatric Infectious Diseases
Oregon Health & Science University
Portland, OR, United States

Faculty(s)

Jason Newland, MD (he/him/his)

Professor of Pediatrics
Washington University School of Medicine
Saint Louis, MO, United States
Andrew Haynes, MD

Assistant Professor
Pediatric Infectious Diseases
Children's Hospital Colorado
Aurora, CO, United States
Karen Puopolo, MD, PHD (she/her/hers)

Professor of Pediatrics
Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine
Swarthmore, PA, United States
Rachel Wattier, MD, MHS (she/her/hers)

Associate Professor of Clinical Pediatrics
University of California, San Francisco
San Francisco, CA, United States
RG

Ryan Gise, MD

Attending Physician, Pediatric ophthalmology and neuro-ophthalmology
Boston Childrens Hospital
Boston, MA, United States
Pablo J. Sánchez, MD

Disclosure(s):

Latania K. Logan, MD;MS: No financial relationships to disclose

Judith Guzman-Cottrill, DO: No financial relationships to disclose

CME Credits: Maximum of 1.75 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.75 hours of MOC Credit
CNE Credits: Maximum of 1.75 hours of ANCC Credit
ACPE Credits: ACPE 1.75 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-23-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe knowledge of available data to inform decision regarding treatment of neonatal UTI, factors to consider when recommending a specific drug, route of administration, and duration of therapy;
describe available data to inform whether repeat LPs are warranted in neonates with gram-negative bacterial meningitis;
describe differences between candida chorioretinitis and candida endophthalmitis based on anatomic location, relative incidence, and potential impact on visual outcome

Presentations:

1:30 PM – 1:48 PM US ET

Neonates With UTI Should Be Treated With IV and Oral Therapy – PRO
Debate Style Speaker: Jason Newland, MD (he/him/his) – Washington University School of Medicine
1:48 PM – 2:05 PM US ET

Neonates With UTI Should Be Treated With IV Therapy Only – CON
Debate Style Speaker: Andrew Haynes, MD – Children's Hospital Colorado
2:05 PM – 2:20 PM US ET

YES! A Lumbar Puncture Should Be Performed to Determine the End of Antibiotic Therapy in Neonatal Gram-Negative Meningitis! – PRO
Debate Style Speaker: Pablo J. Sanchez, MD – Nationwide Children's Hospital - The Ohio State University
2:20 PM – 2:40 PM US ET

Lumbar Punctures Are Not Necessary to Determine the End of Therapy in Neonatal Gram-Negative Meningitis – CON
Debate Style Speaker: Karen M. Puopolo, MD, PHD (she/her/hers) – Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine
2:40 PM – 2:57 PM US ET

A Dilated Retinal Exam Should Be Completed in All Pediatric Patients With Candidemia – PRO
Debate Style Speaker: Rachel L. Wattier, MD, MHS (she/her/hers) – University of California, San Francisco
2:57 PM – 3:15 PM US ET

A Dilated Retinal Exam Should Not Be Completed in All pediatric Patients With Candidemia – CON
Debate Style Speaker: Ryan Gise, MD – Boston Childrens Hospital